Preoperative β-Blocker Therapy and Stroke or Major Adverse Cardiac Events in Major Abdominal Surgery: A Retrospective Cohort Study

被引:6
|
作者
McKenzie, Nicholas L. [1 ]
Ward, R. Parker [2 ]
Nagele, Peter [3 ]
Rubin, Daniel S. [3 ,4 ]
机构
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL USA
[2] Univ Chicago, Sect Cardiol, Chicago, IL USA
[3] Univ Chicago, Med Ctr, Dept Anesthesia & Crit Care, Chicago, IL USA
[4] 5841 S Maryland Ave MC 4028, Chicago, IL 60637 USA
关键词
PERIOPERATIVE CARDIOVASCULAR EVALUATION; 2014 ACC/AHA GUIDELINE; NONCARDIAC SURGERY; MORTALITY; RISK; ASSOCIATION; MANAGEMENT; MORBIDITY; ATENOLOL; INDEX;
D O I
10.1097/ALN.0000000000004404
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background:Perioperative beta-blocker therapy has been associated with increased risk of stroke. However, the association between beta-blocker initiation before the day of surgery and the risk of stroke is unknown. The authors hypothesized there would be no association between preoperative beta-blocker initiation within 60 days of surgery or chronic beta-blockade (more than 60 days) and the risk of stroke in patients undergoing major abdominal surgery. Methods:Data on elective major abdominal surgery were obtained from the IBM (USA) Truven Health MarketScan 2005 to 2015 Commercial and Medicare Supplemental Databases. Patients were stratified by beta-blocker dispensing exposure: (1) beta-blocker-naive, (2) preoperative beta-blocker initiation within 60 days of surgery, and (3) chronic beta-blocker dispensing (more than 60 days). The authors compared in-hospital stroke and major adverse cardiac events between the different beta-blocker therapy exposures. Results:There were 204,981 patients who underwent major abdominal surgery. beta-Blocker exposure was as follows: perioperative initiation within 60 days of surgery for 4,026 (2.0%) patients, chronic beta-blocker therapy for 45,424 (22.2%) patients, and beta-blocker-naive for 155,531 (75.9%) patients. The unadjusted frequency of stroke for patients with beta-blocker initiation (0.4%, 17 of 4,026) and chronic beta-blocker therapy (0.4%, 171 of 45,424) was greater than in beta-blocker-naive patients (0.2%, 235 of 155,531; P < 0.001). After propensity score weighting, patients initiated on a beta-blocker within 60 days of surgery (odds ratio, 0.90; 95% CI, 0.31 to 2.04; P = 0.757) or on chronic beta-blocker therapy (odds ratio, 0.86; 95% CI, 0.65 to 1.15; P = 0.901) demonstrated similar stroke risk compared to beta-blocker-naive patients. Patients on chronic beta-blocker therapy demonstrated lower adjusted risk of major adverse cardiac events compared to beta-blocker-naive patients (odds ratio, 0.81; 95% CI, 0.72 to 0.91; P = 0.007), despite higher unadjusted absolute event rate (2.6% [1,173 of 45,424] vs. 0.6% [872 of 155,531]). Conclusions:Among patients undergoing elective major abdominal surgery, the authors observed no association between preoperative beta-blocker initiation within 60 days of surgery or chronic beta-blocker therapy and stroke.
引用
收藏
页码:42 / 54
页数:13
相关论文
共 50 条
  • [41] Borderline anaemia and postoperative outcome in women undergoing major abdominal surgery: a retrospective cohort study
    Miles, L. F.
    Larsen, T.
    Bailey, M. J.
    Burbury, K. L.
    Story, D. A.
    Bellomo, R.
    ANAESTHESIA, 2020, 75 (02) : 210 - 217
  • [42] Impact of Abdominal Aortic Calcification After Major Hepatobiliary Pancreatic Surgery: A Retrospective Cohort Study
    Imaoka, Yuki
    Ohira, Masahiro
    Sato, Koki
    Imaoka, Kouki
    Bekki, Tomoaki
    Nakano, Ryosuke
    Kuroda, Shintaro
    Tahara, Hiroyuki
    Ide, Kentaro
    Kobayashi, Tsuyoshi
    Tanaka, Yuka
    Ohdan, Hideki
    ANTICANCER RESEARCH, 2022, 42 (12) : 5983 - 5989
  • [43] Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study
    Wasowicz, M.
    Syed, S.
    Wijeysundera, D. N.
    Starzyk, L.
    Grewal, D.
    Ragoonanan, T.
    Harsha, P.
    Travis, G.
    Carroll, J.
    Karkouti, K.
    Beattie, W. S.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (04) : 493 - 500
  • [44] Guideline adherence to statin therapy and association with major adverse cardiac events in high-risk patients following major noncardiac surgery
    Glarner, N. C.
    Puelacher, C.
    Gualandro, D. Menosi
    Buse, G. Lurati
    Gerhard, H.
    Grossenbacher, M.
    Mueller, D.
    Bolliger, D.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] Preoperative Anxiety Among Cardiac Surgery Patients and Its Impact on Major Adverse Cardiac Events and Mortality- A Randomized, Parallel-Group Study
    Mudgalkar, Nikhil
    Kandi, Venkataramana
    Baviskar, Aashish
    Kasturi, Ravinder Reddy
    Bandurapalli, Bindusha
    ANNALS OF CARDIAC ANAESTHESIA, 2022, 25 (03) : 293 - 296
  • [46] γ-Glutamyltransferase Subtype and Major Adverse Cardiac Events
    Ertem, Seyma
    Ertem, Ahmet Goktug
    Erdol, Mehmet Akif
    Demirtas, Koray
    Unal, Sefa
    Karanfil, Mustafa
    Akdi, Ahmet
    Yayla, Cagri
    ANGIOLOGY, 2020, 71 (03) : 292 - 292
  • [47] Getting to the HEART of Major Adverse Cardiac Events
    Samavedam, Srinivas
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2024, 28 (08) : 724 - 725
  • [48] Multimodal prehabilitation before major abdominal surgery: A retrospective study
    Pang, Ning Qi
    He, Stephanie Shengjie
    Foo, Joel Qi Xuan
    Koh, Natalie Hui Ying
    Yuen, Tin Wei
    Liew, Ming Na
    Ramya, John Peter
    Loy, Yijun
    Bonney, Glenn Kunnath
    Cheong, Wai Kit
    Iyer, Shridhar Ganpathi
    Tan, Ker Kan
    Lim, Wan Chin
    Kow, Alfred Wei Chieh
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2021, 50 (12) : 892 - 902
  • [49] Body Mass Index and Major Adverse Cardiovascular Events: A Secondary Analysis Based on a Retrospective Cohort Study
    Liu, Xiaobo
    Liu, Peng
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [50] Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study
    Noumegni, Steve Raoul
    Didier, Romain
    Mansourati, Vincent
    Le Moigne, Emmanuelle
    Le Mao, Raphael
    Hoffmann, Clement
    Moreuil, Claire De
    Tromeur, Cecile
    Le Roux, Pierre-Yves
    Nasr, Bahaa
    Gentric, Jean-Christophe
    Guegan, Marie
    Poulhazan, Elise
    Lacut, Karine
    Bressollette, Luc
    Couturaud, Francis
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (04): : 465 - 480